about
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsMolecular Imaging of Angiogenesis in Cardiac RegenerationMyocardial fibrosis: biomedical research from bench to bedside.A novel concept for ligand attachment to oligonucleotides via a 2'-succinyl linker.Oligonucleotides conjugated to short lysine chains.Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioningSequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodelingInfluence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides.Oligonucleotide conjugates for therapeutic applications.Therapeutic oligonucleotides with polyethylene glycol modifications.EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins.Isolation of eudesmanes from Pluchea odorata and evaluation of their effects on cancer cell growth and tumor invasiveness in vitro.Triterpenoic Acids from Apple Pomace Enhance the Activity of the Endothelial Nitric Oxide Synthase (eNOS).Concise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formation.Long-term regulation of gene expression in muscle cells by systemically delivered siRNA.Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.Off-target effects related to the phosphorothioate modification of nucleic acids.Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.A proteomic study reveals unspecific apoptosis induction and reduction of glycolytic enzymes by the phosphorothioate antisense oligonucleotide oblimersen in human melanoma cells.Oligonucleotide-polyamine conjugates: influence of length and position of 2'-attached polyamines on duplex stability and antisense effect.2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.Fluorescence- and computed tomography for assessing the biodistribution of siRNA after intratracheal application in mice.Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands.Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion.Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.Oligonucleotide charge reversal: 2'-O-lysylaminohexyl modified oligonucleotides.Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.Cardiac Stem Cell-based Regenerative Therapy for the Ischemic Injured Heart — a Short Update 2017Preclinical Studies of Stem Cell Therapy for Heart DiseaseExtrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins
P50
Q27023295-73E93580-9F6F-44A7-A213-6BAAB6A3B0BFQ28073273-448FC51B-43AC-468A-B4F2-79B655A5C978Q30362840-F3FF7A80-2DB7-4BE6-BA5E-6FE9C1D38BDBQ33197337-38D1A02B-DB23-4D66-A933-2EF7E57412C2Q33219918-370E26C7-7A10-4926-8C14-86E485F31748Q37659174-5080E352-E080-48AD-A647-BC0EBD3E88CCQ37683942-666937A2-DA15-4769-99BD-D11C974E7D49Q38085679-32AAC713-6B51-4267-9F0D-331D54192039Q38123854-F82F48B8-E18B-46E2-AB2A-DC5301DA48E3Q38296021-9330AB2D-79FD-4037-9178-236896F516D5Q38350890-15E3D6B8-7CE1-4F29-8469-49BA5D252718Q38701957-7F02ED48-83F6-4971-8685-F8346B104031Q38810711-A743F4EB-3DF0-4261-B5EF-8F0F6233D2D2Q38834667-158EA4BF-58ED-4CDC-8452-E04EEF3ABF1AQ39272515-53753E88-5418-486A-9274-9FBE911F0720Q39546867-A81E805F-C900-4032-8E1C-0697F74335C7Q39693685-98A689C2-FC8F-4FD3-A92A-6E04F4744E79Q39766654-223FE127-B5F7-465C-9556-DF00EF3FEFA2Q39838655-A5E104E0-39BA-4639-8B28-4F7471C0CE97Q39852901-21BC7D84-6B7A-4401-A6AA-13BFA481EC38Q40057883-3411E8E5-A16A-4AE5-8D84-E1D8BE66EB17Q40327785-103B9B46-5D79-4BB8-B3AB-3F078A100F04Q40377938-6C2CE423-54A8-4FD2-B0BF-A789F92ACF8AQ42366539-C092F1D9-58F7-461A-95EB-5C3A134B7143Q42376539-0BE1BF6B-4573-423F-9DFB-AD3943181C8EQ46866844-E7BC6CA5-FAAF-40A8-BB28-D70817F66E22Q55441937-4BC1FD0D-19BD-445D-A05F-104380DBC3F7Q56608534-B3D3B881-DCB1-4478-8B68-E7B0E1BE45F4Q88219970-932C4489-FD67-4ADB-A2F4-7A2D9BD62CE2Q88587981-A6363012-75CF-49B2-A7AD-AF9647E5FC72
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johannes Winkler
@ast
Johannes Winkler
@en
Johannes Winkler
@es
Johannes Winkler
@nl
Johannes Winkler
@sl
type
label
Johannes Winkler
@ast
Johannes Winkler
@en
Johannes Winkler
@es
Johannes Winkler
@nl
Johannes Winkler
@sl
prefLabel
Johannes Winkler
@ast
Johannes Winkler
@en
Johannes Winkler
@es
Johannes Winkler
@nl
Johannes Winkler
@sl
P1053
C-3518-2008
P106
P1153
55605779390
P21
P31
P3829
P496
0000-0002-7278-1999